Related Experiment Videos
Prevention of heart failure
Eugene S Smith1, Suzanne Trussell, Laura J Mencer
1Central Arkansas Veterans Healthcare System and University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA. Smitheugenes@uams.edu
Current Opinion in Cardiology
|October 3, 2002
Summary
Preventing heart failure involves managing cardiac risk factors like hypertension and hyperlipidemia. Angiotensin converting enzyme inhibitors show promise in prevention and treatment, alongside other therapies for managing heart failure symptoms.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Therapeutics
Background:
- Heart failure represents a significant global health burden.
- Preventive strategies for heart failure are not extensively researched.
- Interventions often target modifiable cardiac risk factors.
Purpose of the Study:
- To review current strategies for heart failure prevention.
- To discuss interventions for managing established heart failure and preventing recurrence.
Main Methods:
- Review of existing literature and clinical trial data.
- Analysis of therapeutic interventions for cardiac risk factors and heart failure management.
Main Results:
- The HOPE study expanded indications for angiotensin converting enzyme inhibitors in heart failure prevention.
- Established heart failure management includes biventricular pacing, ventricular assist devices, and specialized clinics.
- Standard medical therapies like beta-blockers, diuretics, and spironolactone improve patient outcomes.
Conclusions:
- Managing cardiac risk factors is crucial for heart failure prevention.
- A multi-faceted approach including advanced therapies and standard medications improves outcomes for patients with heart failure.